Evidence-based·Updated November 14, 2026·How we grade evidence

Valproate (valproic acid, divalproex)

MedicationAnti-seizure and mood medicine (prescription)

Valproate is a first-choice drug for generalized epilepsy and works well for childhood absence seizures, acute mania and migraine prevention. Its serious risks are rare but real: liver failure (highest in young children and people with certain mitochondrial disorders), pancreatitis, high ammonia and, in pregnancy, a high rate of birth defects and lower IQ in children. Aspirin, CBD and changes in carnitine matter for supplement users.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

People with generalized or absence epilepsy, focal seizures, acute bipolar mania or frequent migraines whose prescriber has judged valproate suitable, and who can keep up liver and blood tests

Common dosing range

Set by your prescriber, often guided by blood levels. Depakote label: mania starts at 750 mg a day in divided doses; epilepsy starts at 10 to 15 mg per kg a day; migraine starts at 250 mg twice daily, up to 1,000 mg a day. Maximum 60 mg per kg a day

When to expect effects

Mania trials lasted 3 weeks, with peak levels usually reached within 14 days; epilepsy doses are raised weekly; migraine prevention is judged over weeks to months

Watch out for

Boxed warnings for liver failure, harm to an unborn baby and pancreatitis. Not for pregnancy or people who could become pregnant unless other medicines have failed. Can raise ammonia and lower carnitine; ask your doctor whether to check them if you feel unusually tired, confused or sick to your stomach

What is it

Valproate is a prescription medicine for epilepsy, bipolar mania and migraine prevention. It is sold as valproic acid capsules and oral solution, and as divalproex sodium (Depakote delayed-release tablets, Depakote ER extended-release tablets and Depakote Sprinkles capsules) and generics; all deliver the same active valproate in the body. The Depakote label approves it for manic episodes of bipolar disorder, complex partial (focal) seizures and absence seizures, and to prevent migraine headaches. It carries boxed warnings for liver failure, harm to an unborn baby and pancreatitis.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You have generalized, absence or hard-to-classify epilepsy and you and your neurologist chose valproate
You have bipolar disorder with a manic episode and your prescriber recommends valproate
You have frequent migraines, are not pregnant and cannot become pregnant or use effective birth control, and your prescriber recommends it for prevention
You can keep up regular liver tests and blood counts

Probably skip if…

You have liver disease, a known POLG mitochondrial disorder or a urea cycle disorder (label contraindications)
You are pregnant, or could become pregnant and are not using effective contraception, and want it for migraine prevention (contraindicated)
You are pregnant or planning pregnancy and other medicines have not yet been tried, for epilepsy or bipolar disorder
You plan to use CBD products or aspirin regularly without telling your prescriber

Evidence at a glance

generalized and hard-to-classify epilepsy

Good Evidence
Effect
Moderate; 12-month remission reached sooner than with lamotrigine (HR 0.76 in SANAD)
Best fit
Children and adults with idiopathic generalized epilepsy
Time
Doses are raised weekly; trials measured 12-month remission over several years

childhood absence epilepsy

Good Evidence
Effect
Large versus lamotrigine (58% vs 29% free of failure); similar to ethosuximide
Best fit
Children with newly diagnosed childhood absence epilepsy
Time
Assessed at 16 weeks

acute manic episodes of bipolar disorder

Good Evidence
Effect
Moderate; responders 48% vs 25% with placebo, similar to lithium
Best fit
Adults hospitalized for acute mania, including those who did not respond to lithium
Time
Within the 3-week trial; label says peak blood levels are usually reached within 14 days

preventing episodic migraine in adults

Good Evidence
Effect
Moderate; RR 2.18 for a 50% drop in headache frequency, NNT 4
Best fit
Adults with frequent episodic migraine who cannot become pregnant or use effective contraception
Time
Judged over weeks to months of daily use

Evidence for 4 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

generalized and hard-to-classify epilepsy

Disease adjunct
Good Evidence

In the SANAD trial, 716 UK children and adults with generalized or unclassifiable epilepsy were randomly assigned to valproate, lamotrigine or topiramate and followed for up to about 7 years. Valproate was significantly better than lamotrigine at reaching 12 months without seizures (HR 0.76) and was stopped less often than topiramate (HR 1.57). A 2022 Cochrane network meta-analysis of individual data found that no drug did better than valproate for generalized tonic-clonic seizures, and that valproate, lamotrigine and levetiracetam did not differ in treatment failure, with lamotrigine and levetiracetam the closest alternatives; it rated this evidence moderate certainty. SANAD was not blinded, and the authors noted that pregnancy risks must be weighed for women of childbearing age. The US label lists absence and complex partial seizures, not generalized tonic-clonic seizures by name.

Effect size
Moderate; 12-month remission reached sooner than with lamotrigine (HR 0.76 in SANAD)
Time to effect
Doses are raised weekly; trials measured 12-month remission over several years
Best fit
Children and adults with idiopathic generalized epilepsy
Less likely
Women and girls who are or could become pregnant, for whom the label advises other medicines first

Bottom line: Valproate is a first choice for generalized epilepsy; lamotrigine and levetiracetam are the closest alternatives.

Evidence is mixed

In SANAD, valproate reached 12-month remission sooner than lamotrigine (HR 0.76), but the 2022 Cochrane network meta-analysis found no difference between valproate, lamotrigine and levetiracetam in treatment failure for generalized seizures (moderate certainty).

childhood absence epilepsy

Disease adjunct
Good Evidence

In a double-blind trial, 453 children with newly diagnosed childhood absence epilepsy were randomly assigned to ethosuximide, valproic acid or lamotrigine. After 16 weeks, 58% on valproic acid and 53% on ethosuximide were still free of treatment failure, compared with 29% on lamotrigine. Problems with attention were more common with valproic acid than ethosuximide (49% vs 33%), and the authors favored ethosuximide for that reason. This is one large trial with 16 weeks of follow-up for its main result.

Effect size
Large versus lamotrigine (58% vs 29% free of failure); similar to ethosuximide
Time to effect
Assessed at 16 weeks
Best fit
Children with newly diagnosed childhood absence epilepsy
Less likely
Children with attention problems, where ethosuximide caused fewer attention side effects

Bottom line: Valproate controls childhood absence seizures as well as ethosuximide and far better than lamotrigine.

acute manic episodes of bipolar disorder

Disease adjunct
Good Evidence

In a 3-week double-blind trial, 179 hospitalized adults with acute mania were randomly assigned to divalproex, lithium or placebo. At least 50% improvement in mania scores was seen in 48% on divalproex and 49% on lithium, compared with 25% on placebo, and divalproex worked about as well in people who had not responded to lithium before. The label notes that benefit beyond 3 weeks has not been shown in controlled trials. This is a single trial.

Effect size
Moderate; responders 48% vs 25% with placebo, similar to lithium
Time to effect
Within the 3-week trial; label says peak blood levels are usually reached within 14 days
Best fit
Adults hospitalized for acute mania, including those who did not respond to lithium
Less likely
Long-term prevention of new mood episodes, which these trials did not test

Bottom line: Divalproex roughly doubled the chance of improving acute mania compared with placebo.

preventing episodic migraine in adults

Disease adjunct
Good Evidence

A 2013 Cochrane review of 10 trials in adults with episodic migraine found that divalproex more than doubled the share of people whose headaches fell by at least half compared with placebo (4 trials, 542 participants; RR 2.18, about 1 extra responder for every 4 treated). Sodium valproate cut headaches by about 4 per 28 days versus placebo in 2 small trials (63 participants). It did not clearly beat flunarizine or propranolol in small head-to-head trials. Valproate does not treat a migraine attack once it starts, and the label forbids this use in pregnancy and in women who could become pregnant without effective contraception.

Effect size
Moderate; RR 2.18 for a 50% drop in headache frequency, NNT 4
Time to effect
Judged over weeks to months of daily use
Best fit
Adults with frequent episodic migraine who cannot become pregnant or use effective contraception
Less likely
People wanting relief during an attack, and anyone pregnant or able to become pregnant without effective contraception

Bottom line: Valproate roughly doubles the chance of halving migraine frequency.

How it works

Valproate's exact mechanism is not fully known; it is thought to raise brain levels of the calming messenger GABA. It is mostly broken down in the liver by glucuronidation and beta-oxidation, the same mitochondrial pathway that burns fats. Usual epilepsy blood levels are 50 to 100 mcg/mL, and much of the drug in blood is bound to proteins. These details explain its main interactions. Valproate binds carnitine (forming valproylcarnitine), can lower carnitine levels and can raise blood ammonia, even when liver tests look normal. Aspirin pushes it off its binding proteins and slows its breakdown, so more active drug circulates. Other drugs that also strain the liver, such as cannabidiol (CBD), add to the risk of liver enzyme rises.

How to take it

1. Typical dose
Your prescriber sets the dose, often by weight and blood levels. The Depakote label starts mania at 750 mg a day in divided doses, raised as quickly as needed. For complex partial seizures it starts at 10 to 15 mg per kg a day, raised by 5 to 10 mg per kg each week. For absence seizures it starts at 15 mg per kg a day. For migraine prevention it starts at 250 mg twice daily; some people use up to 1,000 mg a day. Older adults start lower and go up more slowly.
2. Higher studied dose
The label maximum is 60 mg per kg a day. Usual epilepsy blood levels are 50 to 100 mcg/mL; mania trials aimed for trough levels of 50 to 125 mcg/mL. Low platelets become more likely above 110 mcg/mL in women and 135 mcg/mL in men. In migraine trials, higher doses did not work better.
3. Timing
Taken every day as prescribed, usually in divided doses. If you miss a dose, the label says to take it as soon as possible unless it is almost time for the next one, and not to double the next dose.
4. With food
Can be taken with or without food; the label says taking it with food may help stomach upset. The Medication Guide says not to drink alcohol while taking it.
5. Split dosing
Usually two or more doses a day when the total is above 250 mg. Depakote tablets must be swallowed whole, not crushed or chewed.
6. How long to try
Usually long term for epilepsy. Stopping suddenly can trigger status epilepticus, so any change is gradual and made by your prescriber. For mania, the label notes long-term benefit beyond 3 weeks was not tested in controlled trials, so prescribers re-check whether it is still needed.

What to track

Weakness, tiredness, loss of appetite, vomiting, facial swelling or yellow skin or eyes, especially in the first 6 months (possible liver problem; call your prescriber right away)
Severe stomach pain, nausea or vomiting (possible pancreatitis; seek care promptly)
Unusual drowsiness, confusion or vomiting, or feeling cold, which can signal high ammonia
Easy bruising or bleeding; platelets and clotting tests are checked before surgery and in pregnancy
Mood changes or thoughts of self-harm (tell your prescriber at once)
Hair thinning, tremor and weight gain, which are common and worth raising with your prescriber

Bottom line: Your prescriber sets the dose and the liver and blood tests; never stop or change it on your own.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Nausea, vomiting, stomach pain and diarrheaSleepiness, dizziness, weakness and headacheTremorHair loss or thinningDouble visionWeight gainLow platelet count

Serious risks

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: valproate should not be used for epilepsy or bipolar disorder in women who are pregnant or planning pregnancy, or in women who could become pregnant, unless other medicines have failed or are unacceptable, and then with effective contraception; for migraine prevention it is contraindicated in pregnancy. The label reports a major malformation rate of 9 to 11% with about 1,000 mg a day, up to five times the rate with other anti-seizure monotherapies, a spina bifida risk of about 1 to 2%, and lower IQ at age 6 (97 versus 105 to 108 with other drugs) along with higher risks of autism and ADHD. Folic acid before conception and during pregnancy is routinely recommended, though it is not known whether it lowers these risks with valproate. Do not stop it suddenly if you become pregnant: plan any change with your prescriber. Breastfeeding: valproate passes into breast milk at 1 to 10% of the mother's blood level; the label asks that breastfed infants be watched for jaundice and unusual bruising or bleeding, and the decision is made with your prescriber.

Interactions

Carnitine (L-carnitine)High

Valproate binds carnitine and can lower it; the label lists decreased carnitine among reported effects, and high blood ammonia can occur even with normal liver tests. In one study, plasma carnitine in a patient starting valproate dropped for 1 to 3 weeks and recovered by 3 to 5 weeks, and 10 long-term users had levels similar to controls, so low carnitine is not universal. In a case report, 1 g a day of carnitine lowered ammonia in a woman with valproate-related high ammonia; ask your prescriber whether to check your ammonia or carnitine, and use carnitine only under their supervision.

Aspirin (salicylates)High

Aspirin pushes valproate off its binding proteins and slows its breakdown: in 6 children given fever-reducing doses, the free (active) fraction of valproate rose 4-fold. The standard total valproate blood test may not show this. Valproate can also lower platelets, and the label advises caution with the combination; talk to your prescriber or pharmacist before using aspirin, and do not stop aspirin a doctor prescribed without asking them.

CBD (cannabidiol)High

In trials of prescription cannabidiol (Epidiolex), most liver enzyme rises happened in people also taking valproate: in Lennox-Gastaut and Dravet syndrome trials (10 to 20 mg per kg a day), ALT above 3 times normal occurred in 21% taking valproate without clobazam versus 3% taking neither drug. After approval, high ammonia was also reported, mostly in people taking valproate, clobazam or both. These data come from prescription doses; talk to your neurologist before using any CBD product, as liver tests may be needed.

TopiramateHigh

The label warns that topiramate with valproate has caused high blood ammonia, with or without brain effects, and low body temperature, even in people who tolerated each drug alone. Report unusual drowsiness, vomiting, confusion or feeling cold to your prescriber.

Carbapenem antibiotics (ertapenem, imipenem, meropenem)High

These hospital antibiotics can drop valproate below effective levels and lead to loss of seizure control. Make sure the treating team knows you take valproate so levels can be checked or another antibiotic chosen.

AlcoholHigh

The Depakote Medication Guide says not to drink alcohol while taking it, because the two can affect each other and cause side effects such as sleepiness and dizziness, and the label warns valproate's CNS depression is more likely with another CNS depressant such as alcohol. The label also asks you to tell your provider if you drink before starting, though it does not state that alcohol raises valproate's liver risk. Avoid alcohol, do not drive until you know how valproate affects you, and tell your prescriber if avoiding alcohol is hard.

Biotin (vitamin B7)Moderate

In 75 children on valproate alone, activity of biotinidase (the enzyme that recycles biotin) was much lower at moderate and high doses than in healthy children, and rash and hair loss improved after 10 mg a day of biotin in this uncontrolled study. Hair loss is a common valproate side effect, but evidence that biotin helps is limited; ask your prescriber before trying it. If you take high-dose biotin, tell the lab before blood tests, because 10 mg a day distorted some hormone tests in healthy adults.

Estrogen-containing birth controlModerate

Estrogen-containing contraceptives can speed valproate clearance, lowering its level and possibly increasing seizures. The label asks prescribers to check valproate levels when these are started or stopped, so tell your prescriber before any change.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

The exact product: valproic acid capsules or solution, Depakote delayed-release tablets, Depakote ER extended-release tablets or Depakote Sprinkles capsules; they release the drug at different rates, so switching between them is your prescriber's decision
Tablets swallowed whole, never crushed or chewed
A Medication Guide with every fill, which explains the liver, pregnancy and pancreatitis warnings
A plan for regular liver tests and blood counts from your prescriber

Be skeptical of…

CBD or hemp oils marketed as "safe with seizure medicines" or as a replacement for them
"Liver detox" or "liver support" blends presented as protection against valproate liver injury
Biotin hair products promising to reverse medication hair loss
High-dose L-carnitine products sold as a self-treatment for valproate side effects without medical supervision

Frequently asked questions

Should I take L-carnitine with valproate?⌄

Only if your prescriber advises it. Valproate can lower carnitine and raise ammonia, and carnitine has lowered ammonia in case reports, but studies show low carnitine is not universal in long-term users. If you feel unusually tired, confused or sick to your stomach, ask your doctor whether to check your ammonia and carnitine levels.

Can I take aspirin with valproate?⌄

Talk to your prescriber or pharmacist first. Aspirin raised the active (free) part of valproate 4-fold in a small study, which the usual blood test may miss, and both can affect bleeding. The label advises caution. If a doctor prescribed aspirin for your heart, do not stop it without asking them.

Is CBD safe with valproate?⌄

Talk to your neurologist before using it. In trials of prescription CBD, liver enzyme rises were far more common in people also taking valproate (21% versus 3% without valproate or clobazam), and high ammonia has been reported. Liver tests may be needed.

Will biotin help hair loss from valproate?⌄

The evidence is thin. In one uncontrolled study in children, hair loss and rash improved with biotin, and valproate lowered the activity of the enzyme that recycles biotin. Ask your prescriber before trying it, and tell the lab if you take high-dose biotin, since it can distort some blood tests.

Can I drink alcohol on valproate?⌄

The Medication Guide says not to drink alcohol while taking valproate, because the two can add up to cause sleepiness and dizziness. Talk to your prescriber if this is a concern.

What if I could become pregnant?⌄

The label says valproate should be used in women who could become pregnant only when other medicines have failed or are unacceptable, with effective contraception, and never for migraine prevention in pregnancy. Folic acid is routinely recommended. If you become pregnant, do not stop suddenly; contact your prescriber right away to plan next steps.

References by claim

generalized and hard-to-classify epilepsy

Marson et al., 2007 · PMC (2007) link

Nevitt et al., 2022 · PMC (2022) link

childhood absence epilepsy

Glauser et al., 2010 · PMC (2010) link

acute manic episodes of bipolar disorder

Bowden et al., 1994 · PubMed (1994) link

preventing episodic migraine in adults

Linde et al., 2013 · PMC (2013) link

Safety

Depakote (divalproex sodium delayed-release tablets) prescribing information · DailyMed (FDA label) link

Interaction: Carnitine (L-carnitine)

Morand et al., 2012 · PubMed (2012) link

Maldonado et al., 2017 · PMC (2017) link

Interaction: CBD (cannabidiol)

Epidiolex (cannabidiol) prescribing information · DailyMed (FDA label) link

Interaction: Biotin (vitamin B7)

Schulpis et al., 2001 · PubMed (2001) link

Li et al., 2017 · PMC (2017) link

Track Valproate (valproic acid, divalproex) with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 14, 2026·Evidence current as of Nov 14, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.